Year-end Sale % OFF 
Abstract
t is known that patients bridged to heart transplantation with ventricular assist device (VAD) have a higher incidence to develop antibodies directed against human leukocyte (HLA). Both HLA antibodies and non-HLA antibodies like major histocompatibility complex class I-related chain A (MICA) and functional autoantibodies against angiotensin type 1 receptor (AT1R) and endothelin receptor A (ETAR) are implicated in pathogenesis of acute rejection (AR) and cardiac allograft vasculopathy (CAV). Therefore, in this study we monitored HLA and non-HLA antibodies in VAD recipients (VADR) during the first year after VAD-implantation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
